Pfizer Inc/ US7170811035 /
2024-11-07 10:10:00 PM | Chg. +0.10 | Volume | Bid1:59:59 AM | Ask1:59:59 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
27.46USD | +0.37% | 48.48 mill. Turnover: 1.19 bill. |
27.52Bid Size: 800 | 27.53Ask Size: 200 | 155.62 bill.USD | 6.01% | 72.26 |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 13,967 | 13,900 | 14,882 | 16,274 | 18,940 | ||||||
Intangible Assets | 35,370 | 28,471 | 25,146 | 43,370 | 64,900 | ||||||
Long-Term Investments | 3,014 | 16,856 | 16,472 | 11,033 | 11,637 | ||||||
Fixed Assets | 134,197 | 119,162 | 121,307 | 145,741 | 183,667 | ||||||
Inventories | 8,283 | 8,046 | 9,059 | 8,981 | 10,189 | ||||||
Accounts Receivable | 8,724 | 7,930 | 11,479 | 10,952 | 11,177 | ||||||
Cash and Cash Equivalents | 1,305 | 1,784 | 1,944 | 416 | 2,853 | ||||||
Current Assets | 32,803 | 35,067 | 59,693 | 51,259 | 43,333 | ||||||
Total Assets | 167,000 | 154,229 | 181,000 | 197,000 | 227,000 |
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 4,220 | 4,309 | 5,578 | 6,809 | 6,710 | ||||||
Long-term debt | 35,955 | 37,133 | 36,000 | 33,000 | 62,000 | ||||||
Liabilities to Banks | 2,104 | 2,162 | 2,249 | - | - | ||||||
Provisions | 5,578 | 4,063 | 349 | - | - | ||||||
Liabilities | 103,553 | 90,756 | 103,538 | 101,084 | 137,712 | ||||||
Share Capital | 468 | 470 | 473 | 476 | 478 | ||||||
Total Equity | 63,447 | 63,473 | 77,462 | 95,916 | 89,288 | ||||||
Minority Interests | 303 | 235 | 262 | 256 | 274 | ||||||
Total liabilities equity | 167,000 | 154,229 | 181,000 | 197,000 | 227,000 |
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 51,750 | 41,908 | 81,288 | 100,330 | 50,914 | ||||||
Depreciation (total) | 6,010 | 4,777 | 5,191 | 5,064 | 4,733 | ||||||
Operating Result | - | - | - | - | - | ||||||
Interest Income | -1,348 | -1,376 | -1,255 | -987 | -585 | ||||||
Income Before Taxes | 17,682 | 7,497 | 24,311 | 34,729 | 1,058 | ||||||
Income Taxes | 1,384 | 477 | 1,852 | 3,328 | -1,100 | ||||||
Minority Interests Profit | 29 | 36 | 45 | 35 | 39 | ||||||
Net Income | 16,273 | 9,616 | 21,979 | 31,372 | 2,119 |
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 12,588 | 14,403 | 32,580 | 29,267 | 8,700 | ||||||
Cash Flow from Investing Activities | -3,945 | -4,271 | -22,546 | -15,783 | -32,278 | ||||||
Cash Flow from Financing | -8,485 | -9,649 | -9,816 | -14,834 | 26,066 | ||||||
Decrease / Increase in Cash | 125 | 475 | 159 | -1,515 | 2,448 | ||||||
Employees | 88,300 | 78,500 | 79,000 | - | - |